home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Giving Interleukin At The Right Time

  March, 5 2001 10:10
your information resource in human molecular genetics
The effectiveness and toxicity of many drugs can be radically affected by the time of day at which they are administered. This is because the body's clock-the suprachiasmatic nucleus, which takes its main cue from environmental light-regulates the peaks and troughs in hormone output, body temperature and other physiological activities throughout a 24 hour period. For example, administering some anticancer drugs during the night can substantially increase their activity compared with a daytime administration.

Based on this premise, Shigehiro Ohdo and colleagues at Kyushu University in Japan have investigated the effects of the antitumor cytokine drug, interferon-a, on circadian rhythms in mice (Nature Medicine, Vol. 7, No. 3, 01 Mar 2001). Repetitive administration of the cytokine disturbs the ability of the body clock to be cued by light and also alters the rhythm of clock-gene expression in the periphery and in the suprachiasmatic nucleus. These effects may explain some of the toxicity that is associated with this drug, which could be avoided by altering the dosage schedule.


Dr. Shigehiro Ohdo
Department of Clinical Pharmacokinetics
Division of Pharmaceutical Sciences Graduate School
Kyushu University
Higashi-Ku, Fukuoka
Tel: 81 092 642 6658
Fax: 81 092 642 6660
Email: odho@shunsan.phar.kyushu-u.ac.jp

(C) Nature Medicine press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.